Information Provided By:
Fly News Breaks for April 30, 2019
MCRB
Apr 30, 2019 | 08:49 EDT
Jefferies analyst Chris Howerton started Seres Therapeutics with a Hold rating and $7 price target. The analyst believes the company's "Ecobiotics" strategy requires additional work with respect to mechanistic understanding and chemistry, manufacturing and controls.
News For MCRB From the Last 2 Days
There are no results for your query MCRB